Literature DB >> 8375511

Bilirubin attenuates radical-mediated damage to serum albumin.

J Neuzil1, R Stocker.   

Abstract

Oxidative damage to biological macromolecules has been implicated in a number of diseases. Much interest has focused on how non-proteinaceous, low-molecular weight antioxidants prevent oxidative damage to lipids, while comparatively little is known about protein antioxidation. Here we show that bilirubin (BR), the end-product of heme catabolism, when bound to bovine serum albumin (BSA), is oxidised by hydroxyl (.OH), hydroperoxyl (HO2.), and superoxide anion (O2-.) radicals to so far mostly uncharacterised products. The initial oxidation rates of BSA-bound BR decreased in the order OH > HO2. > O2-.. BR protected its carrier protein from oxidative damage inflicted by .OH radicals. This protective action included a reduction in the .OH-mediated cleavage of BSA, conversion of Trp into kynurenine and formation of 'bityrosine-specific' fluorescence. BR also strongly inhibited .OH-mediated formation of protein carbonyls, whereas ascorbate and Trolox (a water-soluble analogue of vitamin E) were much less effective. These results support an antioxidant-protective function of BR and point towards significant differences in the efficacies of various antioxidants in the prevention of oxidative damage to lipids and proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375511     DOI: 10.1016/0014-5793(93)80353-v

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

Review 1.  Clinical use of albumin in hepatology.

Authors:  Matteo Garcovich; Maria Assunta Zocco; Antonio Gasbarrini
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

2.  Spectroscopic studies of the supramolecular interactions between uracil and 5-hydroxy-6-methyluracil with bovine serum albumin and its bilirubin complex.

Authors:  Alexey V Solomonov; Evgeniy V Rumyantsev; Sergey P Ivanov; Boris A Kochergin; Elena V Antina
Journal:  Protein J       Date:  2013-06       Impact factor: 2.371

Review 3.  The heme oxygenases: important regulators of pregnancy and preeclampsia.

Authors:  Eric M George; Junie P Warrington; Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-04       Impact factor: 3.619

Review 4.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

5.  Modification of human serum albumin under induced oxidation.

Authors:  M G Gorobets; L A Wasserman; A D Vasilyeva; A V Bychkova; P G Pronkin; A E Bugrova; M I Indeykina; N G Shilkina; M L Konstantinova; A S Kononikhin; E N Nikolaev; M A Rosenfeld
Journal:  Dokl Biochem Biophys       Date:  2017-07-20       Impact factor: 0.788

6.  Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats.

Authors:  Eric M George; Marietta Arany; Kathy Cockrell; Megan V Storm; David E Stec; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-24       Impact factor: 3.619

Review 7.  Biochemistry and pathology of radical-mediated protein oxidation.

Authors:  R T Dean; S Fu; R Stocker; M J Davies
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

8.  Bilirubin oxidation products (BOXes): synthesis, stability and chemical characteristics.

Authors:  W L Wurster; G J Pyne-Geithman; I R Peat; J F Clark
Journal:  Acta Neurochir Suppl       Date:  2008

9.  Bilirubin increases the expression of glucose transporter-1 and the rate of glucose uptake in vascular endothelial cells.

Authors:  Guy Cohen; Dan M Livovsky; Jaime Kapitulnik; Shlomo Sasson
Journal:  Rev Diabet Stud       Date:  2006-11-10

10.  Bilirubin and its oxidation products damage brain white matter.

Authors:  Katarina Lakovic; Jinglu Ai; Josephine D'Abbondanza; Asma Tariq; Mohammed Sabri; Abdullah K Alarfaj; Punarjot Vasdev; Robert Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-27       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.